Amit K. Sachdev
Executive Vice President and Chief Patient Officer
Amit has dedicated more than 15 years of his career to various leadership positions across Vertex, including establishing our first international commercial function in 2010. He joined the company in 2007, and he leads our efforts to build and strengthen relationships with patient communities globally across the diseases Vertex is pursuing.
He earned a B.S. from Carnegie Mellon University and a J.D. from Emory University. Prior to Vertex he held roles with the Biotechnology Innovation Organization (BIO), the U.S. Food and Drug Administration and the U.S. House of Representatives. He currently serves on the board of directors of Eiger BioPharmaceuticals.
Amit has dedicated more than 15 years of his career to various leadership positions across Vertex, including establishing our first international commercial function in 2010. He joined the company in 2007, and he leads our efforts to build and strengthen relationships with patient communities globally across the diseases Vertex is pursuing.
He earned a B.S. from Carnegie Mellon University and a J.D. from Emory University. Prior to Vertex he held roles with the Biotechnology Innovation Organization (BIO), the U.S. Food and Drug Administration and the U.S. House of Representatives. He currently serves on the board of directors of Eiger BioPharmaceuticals.
Featured content by Amit
We are with you: A message to the sickle cell community
Vertex is committed to the sickle cell disease community. Beyond our science, it’s about showing up and locking arms with the community to work together toward meaningful change.
A new Partnership to ignite change for sickle cell disease
The Sickle Cell Disease Partnership is a multistakeholder coalition, launched in June, which works to improve care and access for people living with sickle cell disease. Here, Chief Patient Officer Amit Sachdev discusses the partnership, its goals and the reasons it was founded.